|
|
|
|
LEADER |
01831nam a22003255i 4500 |
001 |
000283580 |
005 |
20210820131513.0 |
007 |
cr nn 008mamaa |
008 |
160830s2016 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319422237
|
024 |
7 |
|
|a 10.1007/978-3-319-42223-7
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy /
|c edited by Emmanuel Donnadieu.
|
250 |
|
|
|a 1st ed. 2016.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
300 |
|
|
|a VIII, 199 p. 27 illus., 19 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Resistance to Targeted Anti-Cancer Therapeutics,
|v 9
|
505 |
0 |
|
|a Introduction -- Basic rules of T cell migration -- Regulation of anti-tumor T cell migration and function: contribution of real-time imaging -- Vascular normalization, T cell trafficking and anti-tumor immunity -- Disruption of anti-tumor T cell responses by cancer-associated fibroblasts -- Cancer-associated Tertiary Lymphoid Structures, from basic knowledge toward therapeutic target in clinic -- Homing Improvement: Boosting T Cell Trafficking for Cancer Immunotherapy -- Chemokines and T cell trafficking into tumors. Strategies to enhance recruitment of T cells into tumors -- Strategies to enhance migration and persistence of chimeric antigen receptor (CAR)-T cells into tumors.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Immunology.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Immunology.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
700 |
1 |
|
|a Donnadieu, Emmanuel.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|